Log In
BCIQ
Print this Print this
 

SAR104772

  Manage Alerts
Collapse Summary General Information
Company Sanofi
DescriptionThrombin-activatable fibrinolysis inhibitor (TAFIa)
Molecular Target Carboxypeptidase B2 (CPB2) (TAFI)
Mechanism of Action 
Therapeutic Modality 
Latest Stage of DevelopmentPhase I
Standard IndicationStroke
Indication DetailsTreat acute ischemic stroke
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today